Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ARCC
ARCC logo

ARCC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ares Capital Corp (ARCC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
19.090
1 Day change
1.65%
52 Week Range
23.410
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Ares Capital Corp (ARCC) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company offers an attractive dividend yield of 10.5% and insider buying has increased significantly, the recent financial performance shows declining revenue, net income, and EPS. Additionally, the stock's technical indicators are neutral, and there are no strong proprietary trading signals or significant positive catalysts to justify an immediate buy decision.

Technical Analysis

The MACD histogram is positive and expanding, indicating a potential upward trend. However, the RSI is neutral at 66.699, and moving averages are converging, suggesting no clear directional signal. Key support and resistance levels are at 18.289 (pivot), R1: 18.877, and S1: 17.701.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
9

Positive Catalysts

  • The stock offers a high dividend yield of 10.5%, making it appealing for income-focused investors. Insider buying has increased by 165.49% over the last month, indicating confidence from insiders.

Neutral/Negative Catalysts

  • Recent financial performance shows a decline in revenue (-5.55% YoY), net income (-17.93% YoY), and EPS (-25.45% YoY). Analysts have lowered price targets, reflecting lower multiples and higher scrutiny in the business development company space. No recent congress trading data or significant hedge fund activity.

Financial Performance

In 2025/Q4, revenue dropped to $715M (-5.55% YoY), net income fell to $293M (-17.93% YoY), EPS declined to 0.41 (-25.45% YoY), and gross margin decreased to 70.63 (-6.20% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have recently lowered price targets. Keefe Bruyette reduced the target to $21 from $22, UBS to $19 from $21, and JPMorgan to $19 from $22. Ratings remain mixed, with Outperform, Neutral, and Overweight recommendations.

Wall Street analysts forecast ARCC stock price to rise
4 Analyst Rating
Wall Street analysts forecast ARCC stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 18.780
sliders
Low
20
Averages
21.75
High
23
Current: 18.780
sliders
Low
20
Averages
21.75
High
23
Keefe Bruyette
Paul Johnson
Outperform
to
Outperform
downgrade
$22 -> $21
AI Analysis
2026-04-16
New
Reason
Keefe Bruyette
Paul Johnson
Price Target
$22 -> $21
AI Analysis
2026-04-16
New
downgrade
Outperform
to
Outperform
Reason
Keefe Bruyette analyst Paul Johnson lowered the firm's price target on Ares Capital to $21 from $22 and keeps an Outperform rating on the shares.
UBS
Neutral
downgrade
$21 -> $19
2026-03-13
Reason
UBS
Price Target
$21 -> $19
2026-03-13
downgrade
Neutral
Reason
UBS lowered the firm's price target on Ares Capital to $19 from $21 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ARCC
Unlock Now

People Also Watch